1. Home
  2. JKS vs MNKD Comparison

JKS vs MNKD Comparison

Compare JKS & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$19.19

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.92

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JKS
MNKD
Founded
2006
1991
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2010
2004

Fundamental Metrics

Financial Performance
Metric
JKS
MNKD
Price
$19.19
$3.92
Analyst Decision
Hold
Buy
Analyst Count
5
8
Target Price
$24.80
$8.69
AVG Volume (30 Days)
791.5K
4.9M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
6.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$348,966,000.00
Revenue This Year
N/A
$35.81
Revenue Next Year
$14.60
$11.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.23
52 Week Low
$17.37
$2.23
52 Week High
$31.88
$6.51

Technical Indicators

Market Signals
Indicator
JKS
MNKD
Relative Strength Index (RSI) 39.91 63.23
Support Level $17.37 $3.30
Resistance Level $26.68 $3.94
Average True Range (ATR) 1.24 0.23
MACD -0.11 0.03
Stochastic Oscillator 32.74 80.13

Price Performance

Historical Comparison
JKS
MNKD

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: